Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MGC018 |
Trade Name | |
Synonyms | |
Drug Descriptions |
MGC018 is a humanized monoclonal anti-B7-H3 (CD276) antibody in conjugation with a cytotoxic agent (vc-seco-DUBA), which may specifically target B7-H3-expressing tumor cells (Cancer Res 2018;78(13 Suppl):Abstract nr 820, PMID: 32967924). |
DrugClasses | CD276 Antibody 16 |
CAS Registry Number | NA |
NCIT ID | C159495 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MGC018 | MGC018 | 0 | 3 |
MGC018 + MGD019 | MGC018 MGD019 | 0 | 1 |
MGC018 + Retifanlimab | MGC018 Retifanlimab | 0 | 1 |